Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
Published Online: 2019-06-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Antoine Yver•Caleb Lee•Charles Redfern•Haeseong Park•Hiroji Iwata•Ian E Krop•Javad Shahidi•Junji Tsurutani•Kenji Tamura•Masahiro Sugihara•Rashmi K Murthy•Rebecca A Redman•Shanu Modi•Shunji Takahashi•Takahiro Jikoh•Toshihiko Doi•Yasuaki Sagara
